[ad_1]
David Eidelberg, a professor at the Feinstein Institute for Medical Research, won the fourth annual Bachmann-Strauss Award for Excellence in Dystonia Research.
Eidelberg received an unrestricted grant of $ 100,000 for its use of innovative brain imaging techniques and computational algorithms to better understand the pathophysiology of this disorder and its treatment.
Michael J. Fox and Todd Sherer, CEO of the Michael J. Fox Foundation for Parkinson's Research, presented the award at an event in New York on November 10th.
"I am honored to be on the list of Bachmann-Strauss Award winners, who are leading researchers in the field of dystonia," said Eidelberg. "With financial support from MJFF, I can continue to better understand the cause and identify treatments for dystonia."
Dystonia is a movement disorder and a common symptom of Parkinson's disease. Patients with dystonia undergo involuntary muscle movements on one side or the other of the body. The condition can be genetic or caused by damage to the nervous system.
Those who possess the dystonia gene do not always contract the disease, which adds to the mystery of this disease. There is currently no cure for dystonia; the medical community can only treat the symptoms.
Eidelberg has been recognized for his pioneering work in the use of brain imaging and network modeling to identify abnormal brain circuits in people with dystonia. Using these new techniques, he showed how genetic mutations affect the development of dysfunctional brain circuits, and why some people with the mutation have symptoms of the disorder while others do not. did not have any.
Eidelberg's studies also shed light on the location and severity of symptoms in each patient. This has led to new image-based methods for assessing individuals with different forms of dystonia and helping to objectively evaluate their response to treatment.
Presented as part of the partnership between the Bachmann-Strauss Dystonia & Parkinson Foundation and the Michael J. Fox Foundation, the Bachmann-Strauss Prize raises public awareness and recognizes the major scientific discoveries in the field of dystonia. The award rewards Dystonia researchers for their key scientific discoveries and encourages the next generation of researchers to continue to chart their way to curative treatments.
"Dr. Eidelberg's contributions to understanding Parkinson's can not be overstated, "said Dr. Kevin Tracey, President and CEO of the Feinstein Institute. "His research has opened important new avenues for mapping brain networks, which are fundamental to understanding debilitating movement disorders."
[ad_2]
Source link
